From FDA reports: drug interactions between Sorafenib, Entecavir, Hepa Merz [ornithine Aspartate], Lactulose, Ursodiol for a Male patient aged 47

This is a personalized study of Sorafenib, Entecavir, Hepa Merz [ornithine Aspartate], Lactulose, Ursodiol drug interactions for a 47 year old male patient. The study is created by eHealthMe based on 3 reports from FDA.

Do you have a question? Healthcare is personal: one drug can work differently between women and men, or for people of different ages. How do you find patients like you to answer your question, and ensure only patients like you can answer it? Our Personalized Q&A can help. Start now

On Apr, 14, 2013: 3 people who reported to have interactions when taking Sorafenib, Entecavir, Hepa Merz [ornithine Aspartate], Lactulose, Ursodiol are studied

Information of the patient in this study:

Age: 47

Gender: male

Conditions: Hepatic Neoplasm Malignant

Drugs taking:
- Sorafenib: used for 1 - 6 months
- Entecavir: used for 1 - 6 months
- Hepa Merz [ornithine Aspartate]: used for 1 - 6 months
- Lactulose: used for 1 - 6 months
- Ursodiol: used for 1 - 6 months

Drug interactions have: Hepatic Neoplasm Malignant, Disease Progression, Diarrhoea

eHealthMe real world results:

For males aged 47 (±5):

Comparison with this patient's adverse outcomes:

Most common interactions experienced by males aged 47 (±5) in the use of Sorafenib, Entecavir, Hepa Merz [ornithine Aspartate], Lactulose, Ursodiol:

Login or sign up (it's free) to view more results. Or personalize this study

Most common interactions experienced by males aged 47 (±5) in long term use of Sorafenib, Entecavir, Hepa Merz [ornithine Aspartate], Lactulose, Ursodiol:

For people in general (regardless of gender or age):

Comparison with this patient's adverse outcomes:

Most common interactions experienced by people in the use of Sorafenib, Entecavir, Hepa Merz [ornithine Aspartate], Lactulose, Ursodiol:

Login or sign up (it's free) to view more results. Or personalize this study

Most common interactions experienced by people in long term use of Sorafenib, Entecavir, Hepa Merz [ornithine Aspartate], Lactulose, Ursodiol:

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Next: study your drugs OR ask a question from Patients Like You

In-depth study of side effects (who have it, when it happens and how):

• Hepatic Neoplasm Malignant in Lactulose (57 reports)
• Hepatic Neoplasm Malignant in Ursodiol (27 reports)
• Disease Progression in Lactulose (184 reports)
• Disease Progression in Ursodiol (38 reports)
• Diarrhoea (Diarrhea) in Lactulose (540 reports)
• Diarrhoea (Diarrhea) in Ursodiol (193 reports)

Could it be a symptom from a condition:

• Disease Progression in Hepatic Neoplasm Malignant (115 reports)
• Diarrhoea (Diarrhea) in Hepatic Neoplasm Malignant (1,088 reports)

Related personalized Q&As (what is this?):

Recent related drug studies:

• A study of drug interactions between Baraclude, Famotidine, Novorapid, Urso 250, Nexavar for a patient with Hepatic Neoplasm Malignant. The patient has Liver Disorder
• A study of drug interactions between Lactulose, Betamethasone, Nexavar, Lasix, Avapro, Lantus, Morphine Hcl Elixir, Losartan Potassium, Rabeprazole Sodium, Carbocain, Aminoleban En, Promac [polaprezinc], Lorfenamin, Calblock, Miya Bm, Humalog, Urso 250 for a patient with Hepatic Neoplasm Malignant, Diarrhoea. The patient has Palmar-plantar Erythrodysaesthesia Syndrome, Ascites, Blood Uric Acid Increased, Toxic Encephalopathy, Shock Haemorrhagic, General Physical Health Deterioration, Fatigue, Diarrhoea (Diarrhea), Tumour Haemorrhage
• A study of drug interactions between Brivanib Alaninate Or Placebo, Baraclude, Levofloxacin, Acetaminophen, Nexavar, Humalog, Norvasc, Losartan Potassium, Urso 250, Aminoleban En for a patient with Hepatic Neoplasm Malignant. The patient has Infection, Renal Failure Acute, Acute Hepatic Failure, Disseminated Intravascular Coagulation, Pulmonary Oedema, Adverse Drug Reaction, Platelet Count Decreased (Thrombocytopenia ), Pyrexia (Fever), Liver Abscess (Pyogenic liver abscess)
• A study of drug interactions between Famotidine, Urso 250, Lactulose, Platelets, Oldamin, Tathion, Neo-minophagen C, Adelavin, Albuminar, Primperan Tab, Sorafenib, Glycerin, Lasix, Aspartate Potassium, Zolpidem, Ketoprofen, Cefotiam Hydrochloride, Atarax, Protein Supplements, Rinderon-v, Shakuyakukanzoutou, Loxonin, Aspara K, Pursennid, Keratinamin, Pentazocine Lactate for a patient with Hepatic Neoplasm Malignant, Hyperammonaemia, Ascites, Hypokalaemia, Dyschezia, Oedema, Insomnia, Back Pain, Bile Output Abnormal, Prophylaxis, Headache, Constipation, Prophylaxis Against Gastrointestinal Ulcer. The patient has Hypertension (High blood pressure), Hyperammonaemia
• A study of drug interactions between Cefotaxime, Naloxone, Ultracet, Duphalac, Invanz, Duragesic-100, Baraclude, Norpin, Pheniramin, Macperan, Newfenac, Ircodon, Denogan, Peridol, Ativan, Nexavar for a patient with Abdominal Pain, Constipation, Pyrexia, Hepatitis B, Hypotension, Premedication, Nausea, Hepatic Neoplasm Malignant, Confusional State. The patient has Acute Hepatic Failure, Asthenia (Weakness)
• A study of drug interactions between Magnesium Oxide, Lansoprazole, Urso 250, Baraclude, Fentanyl-100, Aldactone, Sorafenib, Lasix, Promac [polaprezinc], Gasmotin, Glakay, Zolpidem for a patient with Hepatic Neoplasm Malignant, Insomnia. The patient has White Blood Cell Count Decreased, Jaundice (Jaundice - yellow skin), Palmar-plantar Erythrodysaesthesia Syndrome, Hepatic Neoplasm Malignant, Blood Pressure Increased (High blood pressure), Hepatic Function Abnormal
• A study of drug interactions between Rabeprazole Sodium, Urso 250, Herbal Preparation, Aldactone, Lasix, Lactulose, Sucralfate, Nexavar, Urepearl, Mucosta, Catlep, Naboal, Daikentyuto, Aminoleban En, Livact, Depas for a patient with Hepatic Neoplasm Malignant. The patient has Palmar-plantar Erythrodysaesthesia Syndrome, Hepatic Encephalopathy
• A study of drug interactions between Alendronate Sodium, Aldactone, Urso 250, Lasix, Aspartate Calcium, Lansoprazole, Verapamil Hcl, Levothyroxine Sodium, Lactulose, Evamyl, Sorafenib, Urepearl, Livact, Onealfa, Gascon, Falkamin for a patient with Hypothyroidism, Prophylaxis, Insomnia, Hepatic Neoplasm Malignant. The patient has Hepatic Neoplasm Malignant, Malaise, Decreased Appetite (Appetite - decreased), Hepatic Encephalopathy
• A study of drug interactions between Lactulose, Allopurinol, Urso 250, Simvastatin, Lansoprazole, Trichlormethiazide, Colchicine, Enalapril Maleate, Amlodipine, Miya Bm, Marzulene, Berizym [enzymes Nos], Prolmon, Nexavar for a patient with Gout, Hepatic Function Abnormal, Hypertension, Gastritis, Hepatic Neoplasm Malignant. The patient has Renal Failure (Acute kidney failure), Diarrhoea (Diarrhea)
• A study of drug interactions between Avapro, Losartan Potassium, Urso 250, Lantus, Humalog, Morphine Hydrochloride, Lasix, Rabeprazole Sodium, Lactulose, Nexavar, Betamethasone, Carbocain, Lorfenamin, Aminoleban En, Promac [polaprezinc], Calblock, Miya Bm for a patient with Hepatic Neoplasm Malignant, Diarrhoea. The patient has Blood Uric Acid Increased, Tumour Haemorrhage, Ascites, Liver Carcinoma Ruptured, Hepatic Haemorrhage, Palmar-plantar Erythrodysaesthesia Syndrome, Shock Haemorrhagic, General Physical Health Deterioration, Fatigue, Toxic Encephalopathy, Diarrhoea (Diarrhea)

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent drug studies on eHealthMe: